ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY

Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1443-A1443
Hauptverfasser: Chandrasekhar, Jaya, Colombo, Antonio, Aquino, Melissa, Ong, Tiong Kiam, Ge, Zhen, Farhan, Serdar, Lee, Michael Kang Yin, Iniguez, Andres, Joyce, Lauren, Snyder, Clayton, Sartori, Samantha, Baber, Usman, Morrell, Debbie, Elmore, Francesca, Rowland, Stephen, Mehran, Roxana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A1443
container_issue 11
container_start_page A1443
container_title Journal of the American College of Cardiology
container_volume 71
creator Chandrasekhar, Jaya
Colombo, Antonio
Aquino, Melissa
Ong, Tiong Kiam
Ge, Zhen
Farhan, Serdar
Lee, Michael Kang Yin
Iniguez, Andres
Joyce, Lauren
Snyder, Clayton
Sartori, Samantha
Baber, Usman
Morrell, Debbie
Elmore, Francesca
Rowland, Stephen
Mehran, Roxana
description Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascular disease, prior revascularization and stable angina or non-ST segment elevation MI presentation.
doi_str_mv 10.1016/S0735-1097(18)31984-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2014387495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109718319843</els_id><sourcerecordid>2014387495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1305-ecec4451f71f0621811ee8982289c36e548d09c5d076b6a5477047e695e506d23</originalsourceid><addsrcrecordid>eNqFkF9r2zAUxUXZoFnXj1AQ7KV78KZrWZa0l-I4SiIaW8VSKH0SqayAS9u0djPY2z763GTsdU_3D79zLvcgdAHkGxDIv1vCKUuASH4J4isFKbKEnqAJMCYSyiT_gCb_kFP0aRgeCCG5ADlBvwtrTakLp01t8VS5W6VqPNPF2CqLK7Vaabe2uKhn2Kxdaapxe6vdErulwuM4NXiqTaLqha6VatQMW6dq9wPPG1MdoKqwpXH4xliXVEVzrZyuF7hRC21dc_cZfdxuHod4_reeofVcuXKZrMxCl8UqCUAJS2KIIcsYbDlsSZ6CAIhRSJGmQgaaR5aJlsjAWsLz-3zDMs5JxmMuWWQkb1N6hr4cfV_63es-Dm_-Ybfvn8eTPiWQUcEzyUaKHanQ74ahj1v_0ndPm_6XB-Lfw_aHsP17kh6EP4Tt6ai7Ouri-MLPLvZ-CF18DrHt-hjefLvr_uPwB9E8el4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014387495</pqid></control><display><type>article</type><title>ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Chandrasekhar, Jaya ; Colombo, Antonio ; Aquino, Melissa ; Ong, Tiong Kiam ; Ge, Zhen ; Farhan, Serdar ; Lee, Michael Kang Yin ; Iniguez, Andres ; Joyce, Lauren ; Snyder, Clayton ; Sartori, Samantha ; Baber, Usman ; Morrell, Debbie ; Elmore, Francesca ; Rowland, Stephen ; Mehran, Roxana</creator><creatorcontrib>Chandrasekhar, Jaya ; Colombo, Antonio ; Aquino, Melissa ; Ong, Tiong Kiam ; Ge, Zhen ; Farhan, Serdar ; Lee, Michael Kang Yin ; Iniguez, Andres ; Joyce, Lauren ; Snyder, Clayton ; Sartori, Samantha ; Baber, Usman ; Morrell, Debbie ; Elmore, Francesca ; Rowland, Stephen ; Mehran, Roxana</creatorcontrib><description>Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascular disease, prior revascularization and stable angina or non-ST segment elevation MI presentation.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(18)31984-3</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Bioengineering ; Cardiology ; Clinical outcomes ; Diabetes ; Diabetes mellitus ; Implants ; Mascots ; Stents ; Surgical implants</subject><ispartof>Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1443-A1443</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109718319843$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Chandrasekhar, Jaya</creatorcontrib><creatorcontrib>Colombo, Antonio</creatorcontrib><creatorcontrib>Aquino, Melissa</creatorcontrib><creatorcontrib>Ong, Tiong Kiam</creatorcontrib><creatorcontrib>Ge, Zhen</creatorcontrib><creatorcontrib>Farhan, Serdar</creatorcontrib><creatorcontrib>Lee, Michael Kang Yin</creatorcontrib><creatorcontrib>Iniguez, Andres</creatorcontrib><creatorcontrib>Joyce, Lauren</creatorcontrib><creatorcontrib>Snyder, Clayton</creatorcontrib><creatorcontrib>Sartori, Samantha</creatorcontrib><creatorcontrib>Baber, Usman</creatorcontrib><creatorcontrib>Morrell, Debbie</creatorcontrib><creatorcontrib>Elmore, Francesca</creatorcontrib><creatorcontrib>Rowland, Stephen</creatorcontrib><creatorcontrib>Mehran, Roxana</creatorcontrib><title>ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY</title><title>Journal of the American College of Cardiology</title><description>Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascular disease, prior revascularization and stable angina or non-ST segment elevation MI presentation.</description><subject>Bioengineering</subject><subject>Cardiology</subject><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Implants</subject><subject>Mascots</subject><subject>Stents</subject><subject>Surgical implants</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkF9r2zAUxUXZoFnXj1AQ7KV78KZrWZa0l-I4SiIaW8VSKH0SqayAS9u0djPY2z763GTsdU_3D79zLvcgdAHkGxDIv1vCKUuASH4J4isFKbKEnqAJMCYSyiT_gCb_kFP0aRgeCCG5ADlBvwtrTakLp01t8VS5W6VqPNPF2CqLK7Vaabe2uKhn2Kxdaapxe6vdErulwuM4NXiqTaLqha6VatQMW6dq9wPPG1MdoKqwpXH4xliXVEVzrZyuF7hRC21dc_cZfdxuHod4_reeofVcuXKZrMxCl8UqCUAJS2KIIcsYbDlsSZ6CAIhRSJGmQgaaR5aJlsjAWsLz-3zDMs5JxmMuWWQkb1N6hr4cfV_63es-Dm_-Ybfvn8eTPiWQUcEzyUaKHanQ74ahj1v_0ndPm_6XB-Lfw_aHsP17kh6EP4Tt6ai7Ouri-MLPLvZ-CF18DrHt-hjefLvr_uPwB9E8el4</recordid><startdate>20180310</startdate><enddate>20180310</enddate><creator>Chandrasekhar, Jaya</creator><creator>Colombo, Antonio</creator><creator>Aquino, Melissa</creator><creator>Ong, Tiong Kiam</creator><creator>Ge, Zhen</creator><creator>Farhan, Serdar</creator><creator>Lee, Michael Kang Yin</creator><creator>Iniguez, Andres</creator><creator>Joyce, Lauren</creator><creator>Snyder, Clayton</creator><creator>Sartori, Samantha</creator><creator>Baber, Usman</creator><creator>Morrell, Debbie</creator><creator>Elmore, Francesca</creator><creator>Rowland, Stephen</creator><creator>Mehran, Roxana</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20180310</creationdate><title>ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY</title><author>Chandrasekhar, Jaya ; Colombo, Antonio ; Aquino, Melissa ; Ong, Tiong Kiam ; Ge, Zhen ; Farhan, Serdar ; Lee, Michael Kang Yin ; Iniguez, Andres ; Joyce, Lauren ; Snyder, Clayton ; Sartori, Samantha ; Baber, Usman ; Morrell, Debbie ; Elmore, Francesca ; Rowland, Stephen ; Mehran, Roxana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1305-ecec4451f71f0621811ee8982289c36e548d09c5d076b6a5477047e695e506d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bioengineering</topic><topic>Cardiology</topic><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Implants</topic><topic>Mascots</topic><topic>Stents</topic><topic>Surgical implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chandrasekhar, Jaya</creatorcontrib><creatorcontrib>Colombo, Antonio</creatorcontrib><creatorcontrib>Aquino, Melissa</creatorcontrib><creatorcontrib>Ong, Tiong Kiam</creatorcontrib><creatorcontrib>Ge, Zhen</creatorcontrib><creatorcontrib>Farhan, Serdar</creatorcontrib><creatorcontrib>Lee, Michael Kang Yin</creatorcontrib><creatorcontrib>Iniguez, Andres</creatorcontrib><creatorcontrib>Joyce, Lauren</creatorcontrib><creatorcontrib>Snyder, Clayton</creatorcontrib><creatorcontrib>Sartori, Samantha</creatorcontrib><creatorcontrib>Baber, Usman</creatorcontrib><creatorcontrib>Morrell, Debbie</creatorcontrib><creatorcontrib>Elmore, Francesca</creatorcontrib><creatorcontrib>Rowland, Stephen</creatorcontrib><creatorcontrib>Mehran, Roxana</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chandrasekhar, Jaya</au><au>Colombo, Antonio</au><au>Aquino, Melissa</au><au>Ong, Tiong Kiam</au><au>Ge, Zhen</au><au>Farhan, Serdar</au><au>Lee, Michael Kang Yin</au><au>Iniguez, Andres</au><au>Joyce, Lauren</au><au>Snyder, Clayton</au><au>Sartori, Samantha</au><au>Baber, Usman</au><au>Morrell, Debbie</au><au>Elmore, Francesca</au><au>Rowland, Stephen</au><au>Mehran, Roxana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-03-10</date><risdate>2018</risdate><volume>71</volume><issue>11</issue><spage>A1443</spage><epage>A1443</epage><pages>A1443-A1443</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascular disease, prior revascularization and stable angina or non-ST segment elevation MI presentation.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(18)31984-3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1443-A1443
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2014387495
source Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Bioengineering
Cardiology
Clinical outcomes
Diabetes
Diabetes mellitus
Implants
Mascots
Stents
Surgical implants
title ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A21%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASSOCIATIONS%20BETWEEN%20DIABETES%20MELLITUS%20AND%20OUTCOMES%20WITH%20THE%20COMBO%20BIO-ENGINEERED%20STENT:%20FROM%20THE%20MASCOT%20POST-MARKETING%20REGISTRY&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Chandrasekhar,%20Jaya&rft.date=2018-03-10&rft.volume=71&rft.issue=11&rft.spage=A1443&rft.epage=A1443&rft.pages=A1443-A1443&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(18)31984-3&rft_dat=%3Cproquest_cross%3E2014387495%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014387495&rft_id=info:pmid/&rft_els_id=S0735109718319843&rfr_iscdi=true